Management of methylphenidate in adults with ADHD: Benefits and risks

被引：0
|
作者：
Simon, N. [1 ]
机构：
[1] Ctr Hosp St Marguerite, Serv Pharmacol, Ctr Antipoison, Marseille, France
来源：
EUROPEAN PSYCHIATRY | 2015年 / 30卷 / 08期
关键词：
Attention-deficit/hyperactive disorder; Addiction; Substance use disorder; Methylphenidate; Pharmacology; DOPAMINE;
D O I：
10.1016/j.eurpsy.2015.09.086
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
S13C
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [41] Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial
    Kooij, S.
    Medori, R.
    Buitelaar, J.
    Ramos-Quiroga, J. A.
    Lee, E.
    Casas, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCIII - XCIII
  • [42] Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies
    Erika Correa
    Timothy Lindsay
    Efrat Dotan
    Drugs & Aging, 2021, 38 : 639 - 654
  • [43] Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies
    Correa, Erika
    Lindsay, Timothy
    Dotan, Efrat
    DRUGS & AGING, 2021, 38 (08) : 639 - 654
  • [44] The effect of treatment duration on methylphenidate discontinuation in adults with ADHD: a meta-analysis
    Cunill, R.
    Castells, X.
    Capella, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S607 - S607
  • [45] Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
    Contini, Veronica
    Victor, Marcelo M.
    Cerqueira, Caio C. S.
    Polina, Evelise R.
    Grevet, Eugenio H.
    Salgado, Carlos A. I.
    Karam, Rafael G.
    Vitola, Eduardo S.
    Belmonte-de-Abreu, Paulo
    Bau, Claiton H. D.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2011, 261 (03) : 205 - 211
  • [46] Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
    Boesen, Kim
    Paludan-Mueller, Asger Sand
    Gotzsche, Peter C.
    Jorgensen, Karsten Juhl
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (02):
  • [47] An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD
    Ni, Hsing-Chang
    Lin, Yu-Ju
    Gau, Susan Shur-Fen
    Huang, Hui-Chun
    Yang, Li-Kuang
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (01) : 27 - 39
  • [48] Attention deficit-hyperactivity disorder drug methylphenidate for adults with approved ADHD
    Schlenger, Ralf
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (05): : 227 - 228
  • [49] Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
    Verônica Contini
    Marcelo M. Victor
    Caio C. S. Cerqueira
    Evelise R. Polina
    Eugênio H. Grevet
    Carlos A. I. Salgado
    Rafael G. Karam
    Eduardo S. Vitola
    Paulo Belmonte-de-Abreu
    Claiton H. D. Bau
    European Archives of Psychiatry and Clinical Neuroscience, 2011, 261 : 205 - 211
  • [50] Acute effects of methylphenidate on neuropsychological parameters in adults with ADHD: possible relevance for therapy
    Kurscheidt, J. C.
    Peiler, P.
    Behnken, A.
    Abel, S.
    Pedersen, A.
    Suslow, T.
    Deckert, J.
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (02) : 357 - 362
12345